Abnormal QTc syndrome in HIV-infected patients: a systematic review of prevalence and risk factors

被引:8
作者
Chastain, Daniel B. [1 ]
Veve, Michael P. [2 ]
Wagner, Jamie L. [3 ]
机构
[1] Univ Georgia, Dept Clin & Adm Pharm, Coll Pharm, Albany, GA 31701 USA
[2] Univ Tennessee, Dept Clin Pharm & Translat Sci, Coll Pharm, Knoxville, TN USA
[3] Univ Mississippi, Dept Pharm Practice, Sch Pharm, Jackson, MS 39216 USA
关键词
TORSADES-DE-POINTES; PENTAMIDINE THERAPY; MACROLIDE ANTIBIOTICS; INTERVAL PROLONGATION; EFAVIRENZ; RILPIVIRINE; DRUG; HERG; ANTIMICROBIALS; ERYTHROMYCIN;
D O I
10.3851/IMP3335
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: The purpose of this review is to critically analyse data regarding the prevalence and risk factors for developing a prolonged QTc interval and subsequent sudden cardiac death (SCD) in persons living with HIV (PLWH). Methods: A systematic literature search using PubMed and Google Scholar databases was performed using the following search terms: 'HIV and prolonged QTc' and 'managing HIV-patients with prolonged QTc'. References within articles of interest were also evaluated. Results/Discussion: PLWH are at an increased risk of having a prolonged QTc interval. Some risk factors for this include the virus itself, concomitant medications, comorbid conditions, addictions and electrolyte disturbances. PLWH who have an increased HIV RNA viral load or decreased CD4(+) T-cell count are at further risk for progressing to sudden cardiac death (SCD). Many medications commonly prescribed in the PLWH population, such as antiretrovirals and antimicrobials used in opportunistic infection prophylaxis, have also been shown to promote QTc prolongation through inhibition of human ether-a-go-go potassium channels or through drug metabolism inhibition of other QTc prolonging drugs. Conclusions: Due to the high number of risk factors associated with QTc prolongation, clinicians should incorporate baseline and routine ECG monitoring for PLWH to potentially lower the increased risk of SCD in PLWH.
引用
收藏
页码:459 / 465
页数:7
相关论文
共 65 条
[1]   Efavirenz Inhibits the Human Ether-A-Go-Go Related Current (hERG) and Induces QT Interval Prolongation in CYP2B6*6*6 Allele Carriers [J].
Abdelhady, Ahmed M. ;
Shugg, Tyler ;
Thong, Nancy ;
Lu, Jessica Bo Li ;
Kreutz, Yvonne ;
Jaynes, Heather A. ;
Robarge, Jason D. ;
Tisdale, James E. ;
Desta, Zeruesenay ;
Overholser, Brian R. .
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2016, 27 (10) :1206-1213
[2]   Macrolide Antibiotics and the Risk of Cardiac Arrhythmias [J].
Albert, Richard K. ;
Schuller, Joseph L. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189 (10) :1173-1180
[3]  
[Anonymous], 2018, FDA DRUG SAFETY COMM
[4]  
[Anonymous], 2018, FDA Drug Safety Communication: Fluoroquinolone
[5]  
[Anonymous], 2019, GUID US ANT AG AD AD
[6]  
[Anonymous], Data 2018
[7]  
Anson BD, 2005, LANCET, V365, P682, DOI 10.1016/S0140-6736(05)70936-3
[8]   Cellular and ionic mechanisms underlying erythromycin-induced long QT intervals and torsade de pointes [J].
Antzelevitch, C ;
Sun, ZQ ;
Zhang, ZQ ;
Yan, GX .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1996, 28 (07) :1836-1848
[9]   Effect of a Modified Saquinavir/Ritonavir Dosing Regimen with Lower Dose Lead-In Phase on QTc Interval, Pharmacokinetics, Antiviral Activity and Safety in Treatment-Naïve HIV-1-Infected Patients [J].
Boffito M. ;
Jackson A. ;
Pozniak A. ;
Giraudon M. ;
Kulkarni R. ;
Abelardo M.C. ;
Patel I.H. ;
Morcos P.N. .
Drugs in R&D, 2015, 15 (1) :141-153
[10]  
Boven K, 2009, IDWEEK